Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma

Figure 3

Validation of the nine immune-related lncRNA signature. (a) Kaplan-Meier analysis for the OS of HCC patients; (b) ROC curve of the signature in predicting the patients’ OS; (c) univariate Cox regression analyses and (d) multivariate Cox regression analyses of the association between clinicopathological factors and OS of HCC patients.

(a)

(b)

(c)

(d)